Company intelligence / Profile preview
Resolution Therapeutics
Edinburgh, Scotland, United Kingdomresolution-tx.com ↗
- Ownership
- Private
- Employees
- ~125
- Development stage
- Phase 1
01
Overview
Resolution Therapeutics has advanced its lead asset, RTX001, an engineered autologous macrophage cell therapy, into a Phase I/II study ("EMERALD") targeting end-stage liver disease. Preclinical data support its anti-fibrotic and anti-inflammatory potential. The OPAL natural history study is ongoing to provide control data for clinical development. No published human efficacy results yet as of May 2025
- Therapeutic areas
- Gastroenterology
- Modalities
- Cell therapy (specifically, engineered autologous macrophages)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
University of Edinburgh / Centre for Regenerative MedicineScottish National Blood Transfusion ServiceSyncona Investment Management Limited (investor/backer)
Beyond the preview
Go deeper on Resolution Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Resolution Therapeutics.